早期护理干预在新生儿黄疸治疗中的应用效果

Application effect of early nursing intervention in treatment of neonatal jaundice

目的探讨采用早期护理干预治疗新生儿黄疸的可行性及安全性。方法选取我院2013年4月~2014年11月收纳的90例新生儿黄疸患儿,随机分为观察组和对照组,各45例,观察组患者用早期护理干预治疗,对照组患者仅进行常规传统护理治疗,其余条件保持相同,对比观察组和对照组患者治疗前后积临床表征及痊愈情况等,且记录治疗过程中是否出现不良反应,治疗1个月后对其疗效进行评价。结果治疗后新生儿黄疸患者胎便初排及胎便转黄所需时间,观察组较之对照组明显减少（P〈0.05）;两组治疗后血清胆红素较之前均有下降,观察组改善情况更为显著（P〈0.05）。结论对新生儿黄疸患者进行早期护理干预明显缩短患者痊愈时间,疗效良好,且明显改善新生儿黄疸患者发病导致的胎便变黄,减少血清胆红素过高等而缓解黄疸,可行性及安全性均较高,无严重不良反应,值得临床上进一步推广应用。

Objective To evaluate the feasibility and safety of nursing intervention treatment for neonatal jaundice,summarize its advantages and compare it to other diagnostic methods. Methods Ninety patients with neonatal jaundice treated in our hospital from April 2013 to November 2014 were selected and divided into the observation group and the control group according to the random allocation principle, with 45 patients in each group. The observation group was given early nursing intervention treatment and the control group was given only conventional and traditional nursing treatment. The other conditions were the same. The observation indicators, such as clinical manifestations and recovery situation, of the observation group and the control group before and after treatment were compared, and the occurrence of adverse reactions during treatment was recorded. The efficacy was evaluated after one month of treatment. Results After treatment, the time of first meconium defecation and the time of meconium turning yellow of the observation group reduced significantly compared to those of the control group, with significant differences（P〈0.05）. After treatment,the serum bilirubin levels of both groups reduced compared to those before treatment, but the observation group improved more significantly, with significant difference（P〈0.05）. Conclusion The application of early nursing intervention in the patients with neonatal jaundice shortens the patients＇ recovery time significantly, shows favorable efficacy, improves the meconium turning yellow situation caused by neonatal jaundice significantly, reduces clinical manifestations such as excessive serum bilirubin, relieves jaundice, has high feasibility and safety, and causes no severe adverse reactions, which is worthy of clinical promotion and application.